InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,831.19
(
-0.57%
)
US TECH 100
19,732.00
(
-0.24%
)
Dow Jones
42,958.92
(
-0.73%
)
Brent Oil
73.41
(
0.67%
)
Bitcoin
66,812.76
(
-3.17%
)
Post# of 253409
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120588
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 107865

Tuesday, 11/02/2010 3:36:55 PM

Tuesday, November 02, 2010 3:36:55 PM

Post# of 253409
Peter et al: Lovenox is certainly not in Teva’s 2010 guidance for revenue and EPS. This is obvious from the numbers themselves and also from Teva’s written statements about its financial guidance.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up